Teleflex Incorporated

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device

WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced the first patient enrollment in the ACCESS-MANTAâ„¢ Registry. This international, multicenter, prospective, observational, single-arm …

Teleflex Launches ACCESS-MANTA Registry to Evaluate MANTA Vascular Closure Device Read More

Teleflex Incorporated

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate

WAYNE, PA — A groundbreaking study published in the Nature journal Prostate Cancer and Prostatic Diseases has bolstered the position of the UroLiftâ„¢ System as the leading minimally invasive surgical …

New Study Reinforces UroLiftâ„¢ System as Gold Standard Treatment for Enlarged Prostate Read More
Aclaris Therapeutics

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More


Annovis Bio

Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease

BERWYN, PA — In a recent breakthrough, Annovis Bio (NYSE: ANVS), a biopharmaceutical company, has successfully performed measurements of critical biomarkers in the plasma of Parkinson’s disease patients. Utilizing buntanetap, …

Annovis Bio’s Buntanetap Demonstrates Potential to Lower Key Biomarkers in Parkinson’s Disease Read More